MSB 4.89% $1.07 mesoblast limited

Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-688

  1. 12,254 Posts.
    lightbulb Created with Sketch. 1091
    Hi Sarge,
    I doubt if SI has time to take anything up.
    He just brought Novartis on board and he would be finalising
    similar deals for CHF and CLBP.

    Kind of silly of you to get critical of trial progress if you knew anything
    you would know normally this trial would take maybe 5 years,

    Mesoblast are just full steam ahead leaving Shade throwers like you in their wake.

    Aloha.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.